FOXA1 and breast cancer: A meta-analysis including nine studies comprised of 6386 patients affected by BC suggested that high FOXA1 expression positively influences disease-free survival (pooled HR: 0.43, 95% CI: 0.23–0.81; p < 0.05) and OS (pooled HR: 0.39, 95% CI: 0.26–0.60; p < 0.05) [65].